Author:
Simon Liz,Primeaux Stefany D.,Levitt Danielle E.,Bourgeois Brianna,Johannsen Neil M.,Peters Adrianna,Ahmed Jameel,Marshall Richard H.,Fairchild Alexandra H.,Ferguson Tekeda F.,Molina Patricia E.
Abstract
Abstract
Background
Effective antiretroviral therapy (ART) in people living with HIV (PLWH) has improved life expectancy and increased risk of age-associated cardiometabolic comorbidities. At-risk alcohol use is more frequent among PLWH and increases the risk of health challenges. PLWH with at-risk alcohol use are more likely to meet criteria for prediabetes/diabetes and this is associated with impaired whole-body glucose-insulin dynamics.
Methods
The Alcohol & Metabolic Comorbidities in PLWH: Evidence Driven Interventions Study (ALIVE-Ex Study, NCT03299205) is a longitudinal, prospective, interventional study to determine the effects of an aerobic exercise protocol on improving dysglycemia among PLWH with at-risk alcohol use. The intervention is a moderate intensity aerobic exercise protocol implemented 3 days per week for 10 weeks at the Louisiana State University Health Sciences Center-New Orleans. Participants who have a fasting blood glucose level between 94 and 125 mg/dl will be enrolled in the study. Oral glucose tolerance tests, fitness assessments, and skeletal muscle biopsies will be performed pre- and post-exercise intervention. The primary outcome is to determine whether the exercise protocol improves measures of whole-body glucose-insulin dynamics, cardiorespiratory fitness, and skeletal muscle metabolic and bioenergetic function. Secondary outcomes are to determine whether the exercise intervention improves cognitive function and overall quality of life. Results generated will demonstrate the effect of exercise on glycemic measures in PLWH with subclinical dysglycemia and at-risk alcohol use.
Conclusions
The proposed intervention will also have the potential to be scalable to promote lifestyle changes among PLWH, particularly in underserved communities.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Virology,Molecular Medicine
Reference61 articles.
1. Willig AL, Webel AR, Westfall AO, Levitan EB, Crane HM, Buford TW, Burkholder GA, Willig JH, Blashill AJ, Moore RD, et al. Physical activity trends and metabolic health outcomes in people living with HIV in the US, 2008–2015. Prog Cardiovasc Dis. 2020;63(2):170–7.
2. Ceccarelli G, Pinacchio C, Santinelli L, Adami PE, Borrazzo C, Cavallari EN, Vullo A, Innocenti GP, Mezzaroma I, Mastroianni CM, et al. Physical activity and HIV: effects on fitness status, metabolism. Inflamm Immune Activ AIDS Behav. 2020;24(4):1042–50.
3. Martin K, Naclerio F, Karsten B, Vera JH. Physical activity and quality of life in people living with HIV. AIDS Care. 2019;31(5):589–98.
4. Guimaraes MMM, Greco DB, Moreira AN, Guimaraes NS, Freire CMV, Rohlfs BG, Machado LJC. Lipid accumulation product index in HIV-infected patients: a marker of cardiovascular risk. Braz J Infect Dis. 2018;22(3):171–6.
5. Willig AL, Overton ET. Metabolic complications and glucose metabolism in HIV infection: a review of the evidence. Curr HIV/AIDS Rep. 2016;13(5):289–96.